A Family of Synergistic
Technology Solutions
Precigen is focused on improving patient care through innovative gene and cell therapies. Our subsidiaries are an important part of realizing this mission as they are advancing a portfolio of unique solutions to address unmet needs in health.
Pioneering a new class of microbe-based pharmaceutical agents through its ActoBiotics™ platform for expression and local delivery of therapeutics at disease sites including the intestine, the mouth and the nasopharynx to treat a range of disorders
Enabling discovery by providing porcine research models and services that aid scientists in the understanding of human disease mechanisms, development of new therapeutics, development of next-generation medical procedures and devices, and optimization of novel diagnostics
